about
Rapid discrimination of MHC class I and killer cell lectin-like receptor allele variants by high-resolution melt analysis.Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothersEducating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey.Cytomegalovirus: pathogen, paradigm, and puzzleIsolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines.Human cytomegalovirus tropism for mucosal myeloid dendritic cells.Prevention of maternal and congenital cytomegalovirus infectionActivation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D LigandHuman cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation.HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals.Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission.VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection.Update on the current status of cytomegalovirus vaccines.Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infectionCytomegalovirus in the neonate: immune correlates of infection and protectionPersistent pathogens linking socioeconomic position and cardiovascular disease in the US.Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection.Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseAnalysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genomeExploiting 2A Peptides to Elicit Potent Neutralizing Antibodies by a Multi-Subunit Herpesvirus Glycoprotein Complex.Human cytomegalovirus early protein pUL21a promotes efficient viral DNA synthesis and the late accumulation of immediate-early transcripts.Congenital viral infections: available strategies to decrease their prevalence.Using theory-based messages to motivate U.S. pregnant women to prevent cytomegalovirus infection: results from formative research.Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.Anti-viral effects of urosolic acid on guinea pig cytomegalovirus in vitro
P2860
Q30417911-675D9E76-EFFA-44F0-8C2E-D5D6D19DE0D5Q30599280-CE519D93-7E95-456D-82D9-FBC96EA09484Q30606105-C302093C-71D4-4A13-A441-067381DE74E1Q33351523-2108CDB9-9C61-4A8D-B1C1-0B304CE0195DQ33558361-48200DB0-FBBB-4EFD-A089-8F484235EC0DQ34360228-FE230158-A04D-4382-83E6-7ABB5C24453AQ34360247-B7A73637-925D-47CA-A299-422E760307B9Q34422068-02B6E890-624F-41A5-BF54-69CBF085AF58Q35945705-485F08A6-0DCC-4CC4-ADE3-C71AA3F4F8EDQ36210368-8F7F59EE-C16E-4A4B-9CFB-195F78C3D77BQ36432667-45426B4C-8C92-4DC7-9A48-3990F2EC1E52Q36484918-2E157168-E49F-4062-A6E0-4E41D12C6814Q36517126-4CF1408C-0F2A-496F-A4E3-1098C22F8417Q36517156-D6B127EA-5785-42BB-AFD3-B874B59B4A8BQ36678423-908F75DD-C4A1-4B22-A38B-D2DDBAC43612Q36830632-AF950483-F925-4DC4-9B03-16134494F96FQ37140130-0124A957-01DC-4E37-9CA9-32752D535405Q37209892-2E2D050C-0145-4C1E-91B2-FD25D0717A4FQ37252571-EA3026DA-E50E-46C8-9392-302BBA4A5070Q37523020-8220A347-957F-48FD-BDF8-22F9EC06F727Q41859984-D27CACF6-DC46-4ED8-B899-46C4B67ABC6CQ41921854-EAD125E0-6D9B-46F5-A6C9-67F097E5EC2EQ42166179-CDA46C18-E698-4309-BF02-4A3F41CF9A7BQ45209956-8ED3EDF2-47AB-4DE7-993B-3029FB55FDF1Q47103053-B4E61CC7-1CE0-44B4-879A-12BF7E519817Q47605886-D09B5B6C-893E-4003-841B-A4B1E3D77759Q57097914-B9D19E68-FC67-48E4-86AC-F2D79CB17947
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cytomegalovirus vaccine development
@ast
Cytomegalovirus vaccine development
@en
type
label
Cytomegalovirus vaccine development
@ast
Cytomegalovirus vaccine development
@en
prefLabel
Cytomegalovirus vaccine development
@ast
Cytomegalovirus vaccine development
@en
P2860
P1476
Cytomegalovirus vaccine development
@en
P2093
M R Schleiss
P2860
P304
P356
10.1007/978-3-540-77349-8_20
P577
2008-01-01T00:00:00Z